EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical Application Guide

What This Product Solves

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride, CAS 25952-53-8) is a widely used water-soluble carbodiimide reagent that addresses the need for efficient, in vitro amide bond formation. It is especially valuable for peptide synthesis, bioconjugation, and nucleotide coupling workflows where aqueous compatibility is essential. By activating carboxyl groups to form reactive intermediates, EDC.HCl enables direct coupling with primary amines under mild, aqueous conditions, streamlining the production of stable amide linkages. Additionally, its solubility profile makes it suitable for workflows that cannot tolerate organic solvents. The reagent is also applicable to esterification and lactonization reactions, expanding its utility within synthetic and analytical biochemistry protocols. Importantly, the absence of in vivo or clinical data limits its use strictly to laboratory-based, in vitro applications. For a detailed product overview, see EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) at APExBIO.

Protocol Parameters

• Solubility in Water: ≥39 mg/mL | Suitable for aqueous peptide synthesis, nucleotide coupling, and bioconjugation reactions | Ensures sufficient reagent concentration for most in vitro workflows | product information
• Storage Conditions: -20°C, desiccated (solid form) | Appropriate for long-term reagent stability | Minimizes hydrolysis and maintains reagent activity; avoid storing solutions for extended periods | product information
• Monitoring Reaction Progress: Spectrophotometric methods (quantitative) | Applicable to tracking EDC consumption or byproduct formation during coupling | Enables QC and troubleshooting via absorbance-based quantification | product information
• Typical Working Concentration: 1–10 mM (workflow recommendation) | Common range for peptide synthesis and bioconjugation | Balances activation efficiency and minimizes side-reactions; optimize per substrate | workflow recommendation
• Solubility in DMSO/Ethanol: ≥19.2 mg/mL (DMSO), ≥39.6 mg/mL (ethanol) | Useful for protocols requiring organic co-solvents | Expands compatibility for poorly water-soluble substrates | product information

Workflow Setup and QC Checklist

To maximize the efficiency and reproducibility of reactions using EDC.HCl, consider the following procedural checklist:

• Confirm reagent identity and integrity before use; inspect for signs of moisture uptake or degradation.
• Prepare EDC.HCl solutions fresh immediately prior to use to prevent hydrolysis and loss of activity; avoid long-term storage of solutions.
• Maintain controlled pH conditions (commonly pH 4.5–7.5 for peptide and bioconjugation workflows) to optimize coupling efficiency and minimize byproduct formation.
• Use an appropriate buffer system that does not contain primary amines (e.g., MES, phosphate) to avoid undesired side reactions.
• Monitor reaction progress using spectrophotometric methods or by analyzing conversion of starting materials and formation of urea byproduct.
• Include negative and positive controls where possible to validate coupling efficiency.
• For product-specific technical guidance, the article Protocol Guidance details in vitro workflow parameters compatible with this reagent.

Common Failure Modes and Fixes

• Hydrolysis of EDC.HCl: Rapid hydrolysis in aqueous solution can reduce coupling efficiency. Always prepare solutions immediately before use and minimize exposure to moisture.
• Incomplete Coupling: Suboptimal pH, insufficient reagent concentration, or presence of competing nucleophiles (e.g., buffer amines) can result in low yields. Adjust pH to 4.5–7.5, confirm substrate purity, and select non-nucleophilic buffers.
• Urea Byproduct Accumulation: EDC-mediated reactions generate urea as a byproduct, which may interfere with downstream applications. Implement purification steps (e.g., dialysis, chromatography) post-reaction to remove urea.
• Precipitation or Poor Solubility: For reactions involving poorly soluble substrates, dissolve EDC.HCl in DMSO or ethanol within specified solubility limits. Verify compatibility of organic co-solvents with your workflow.
• Batch-to-Batch Variability: Use validated QC methods (e.g., spectrophotometry) to monitor reagent performance and ensure reproducibility.
• For more troubleshooting strategies, the article Technical Use discusses additional in vitro application considerations.

Scope and Limitations

EDC.HCl is intended exclusively for in vitro protocols such as peptide synthesis, nucleotide coupling, bioconjugation, and related applications. It should not be used for in vivo or clinical studies, as there are no reported data supporting such uses. The reagent is compatible with aqueous and select organic solvent workflows and is not suitable for protocols involving labile substrates sensitive to carbodiimide chemistry. Always verify downstream compatibility with target biomolecules and buffer components. For a broader overview of use cases and boundaries, see the linked Technical Guide.

Conclusion

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a robust, water-soluble carbodiimide reagent optimized for in vitro peptide synthesis, bioconjugation, and nucleotide coupling. Adhering to recommended storage, handling, and QC practices is critical for reliable performance. For detailed specifications and ordering, refer to the APExBIO product page. Researchers are advised to restrict use to laboratory workflows until further peer-reviewed data are available for alternative applications.